CDC Recommends New Treatment Regimen for Latent Mycobacterium Tuberculosis Infection | AAFP
One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis | NEJM
Latent Tuberculosis (LTBI) Treatment Flowsheet: Dose, Symptom Monitoring, Completion
Latent Tuberculosis Infection: Successful Screening and Treatment of Older Adults in a Program of All-Inclusive Care for the Elderly (PACE)
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf
3HP for Latent TB Infection Treatment | CDC
Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article
Isoniazid (oral) - wikidoc
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial - The Lancet HIV
A Lazy Person's Guide to Latent Tuberculosis Treatment in Patients with HIV - Southeast AIDS Education & Training Center
1.4. Tuberculosis preventive treatment options | TB Knowledge Sharing
Table 3 from Treatment of Latent Tuberculosis Infection. | Semantic Scholar
Tuberculosis: Insidious But Treatable
Chapter 5.1 Recommended dosages of TPT medication | TB Knowledge Sharing
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Dosing regimens for tuberculosis | Download Table
Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital | Scientific Reports
Tuberculosis: Current Treatments and Investigational Therapies
Tuberculosis Series: Treatment - EthnoMed
Children with latent TB adhere to rifampin better than isoniazid
LTBI | Features | TB | CDC
4 months of rifampin for latent TB shows promise
